close 73% jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 73% jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse. Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
Change languageEesti
Ülevaade

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

Kodu・Aktsiate loetelu・Lyell Immunopharma Inc
Search

Lyell Immunopharma Inc

Suletud

16.77 -3.29

Neutraalne

Hinna uuendus 14. nov 2025, 20:57 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

16.76

Max

17.04

Põhinäitajad

By Trading Economics

Sissetulek

9.5M

-43M

Müük

1K

8K

Aktsiakasum

-2.89

Kasumimarginaal

-533,550

Töötajad

300

EBITDA

11M

-43M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

-17.31% downside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

19. nov 2025

Turustatistika

By TradingEconomics

Turukapital

136M

340M

Eelmine avamishind

20.06

Eelmine sulgemishind

16.77

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

0.4217 / 0.4691 Toetus ja vastupanu

Lyell Immunopharma Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

14. nov 2025, 17:45 UTC

Tulu
Suurimad hinnamuutused turgudel

Figure Technology Shares Rise After Higher 3Q Earnings, Revenue

DJ

Loe

14. nov 2025, 17:31 UTC

Tulu
Suurimad hinnamuutused turgudel

American Bitcoin Advances on 3Q Profit, Eric Trump's Crypto Confidence

DJ

Loe

15. nov 2025, 18:03 UTC

Tulu

Kugler Resignation From Fed Board Followed Disclosures of Improper Stock Trades -- UPDATED -- WSJ

DJ

Loe

15. nov 2025, 15:43 UTC

Tulu

Kugler Resignation From Fed Board Followed Disclosures of Improper Stock Trades -- WSJ

DJ

Loe

15. nov 2025, 09:20 UTC

Market Talk
Tulu

Tech, Media & Telecom Roundup: Market Talk

DJ

Loe

15. nov 2025, 09:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

DJ

Loe

15. nov 2025, 00:08 UTC

Omandamised, ülevõtmised, äriostud

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 3rd Update

DJ

Loe

14. nov 2025, 23:56 UTC

Omandamised, ülevõtmised, äriostud

Berkshire Hathaway Bought Alphabet Shares Worth $4.3 Billion in the Third Quarter. Here's What It Sold. -- Barrons.com

DJ

Loe

14. nov 2025, 23:02 UTC

Market Talk

Chinese Battery Makers Benefit From U.S. Rising Demand -- Market Talk

DJ

Loe

14. nov 2025, 22:35 UTC

Tulu
Omandamised, ülevõtmised, äriostud

The Score: Tyson, Robinhood, Walmart, Paramount Skydance and More Stocks That Defined the Week -- WSJ

DJ

Loe

14. nov 2025, 22:32 UTC

Omandamised, ülevõtmised, äriostud

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 2nd Update

DJ

Loe

14. nov 2025, 22:29 UTC

Tulu

Starbucks Scores on Holiday Sales. It's a Good Sign for the Turnaround. -- Barrons.com

DJ

Loe

14. nov 2025, 22:00 UTC

Omandamised, ülevõtmised, äriostud

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- Update

DJ

Loe

14. nov 2025, 21:50 UTC

Market Talk
Tulu

Tech, Media & Telecom Roundup: Market Talk

DJ

Loe

14. nov 2025, 21:18 UTC

Omandamised, ülevõtmised, äriostud

Berkshire Buys Shares of Alphabet and Pares Apple Stake -- WSJ

DJ

Loe

14. nov 2025, 20:27 UTC

Market Talk

Oil Futures Rise After Ukraine Strikes Russian Port -- Market Talk

DJ

Loe

14. nov 2025, 20:23 UTC

Market Talk

U.S. Natural Gas Futures Post Weekly Gain -- Market Talk

DJ

Loe

14. nov 2025, 20:17 UTC

Omandamised, ülevõtmised, äriostud

Several State Attorneys General Oppose Railroad Merger -- WSJ

DJ

Loe

14. nov 2025, 19:29 UTC

Market Talk
Tulu

Applied Materials' F4Q Results Seen as 'Uninspiring' -- Market Talk

DJ

Loe

14. nov 2025, 18:44 UTC

Market Talk
Tulu

Disney's Growth Now Hinges More on ESPN -- Market Talk

DJ

Loe

14. nov 2025, 18:27 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Loe

14. nov 2025, 18:27 UTC

Market Talk

Morgan Stanley Sees 'Worthy Successor' in Walmart CEO Furner -- Market Talk

DJ

Loe

14. nov 2025, 18:20 UTC

Market Talk

U.S. Oil Rig Count Rises by 3 to 417 -- Market Talk

DJ

Loe

14. nov 2025, 17:20 UTC

Market Talk
Tulu

Auto & Transport Roundup: Market Talk

DJ

Loe

14. nov 2025, 17:20 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Health Care Roundup: Market Talk

DJ

Loe

14. nov 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

DJ

Loe

14. nov 2025, 16:51 UTC

Market Talk

Starbucks Gets Holiday Sales Lift -- Market Talk

DJ

Loe

14. nov 2025, 16:48 UTC

Market Talk

Gold Slides Amid Selloff, Lower December Fed Rate-Cut Expectations -- Market Talk

DJ

Loe

14. nov 2025, 16:38 UTC

Market Talk

Unica Reports Higher Brazilian Sugar and Ethanol Production -- Market Talk

DJ

Loe

14. nov 2025, 16:30 UTC

Omandamised, ülevõtmised, äriostud

Merck Is Paying Up for Flu Biotech as M&A Spree Continues -- Barrons.com

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

Lyell Immunopharma Inc Prognoos

Hinnasiht

By TipRanks

-17.31% langus

12 kuu keskmine prognoos

Keskmine 14 USD  -17.31%

Kõrge 20 USD

Madal 10 USD

Põhineb 3 Wall Streeti analüütiku instrumendi Lyell Immunopharma Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

3 ratings

1

Osta

1

Hoia

1

Müü

Põhineb 3 analüütiku instrumendi Lyell Immunopharma Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

0.4217 / 0.4691Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Keskpikk perspektiiv

Weak Bearish Evidence

There is one bearish event.

Pikk perspektiiv

No Evidence

There are no events.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Muud aktsiad sektorist

LLY

Eli Lilly and Co.

1,023.96

↑ +0.31%

JNJ

Johnson and Johnson

196.01

↑ +0.34%

ABBV

AbbVie Inc

232.37

↓0%

UNH

UnitedHealth Group Inc

321.37

↓-3.25%

AZN

AstraZeneca PLC ADR

89.14

↑ +0.64%
help-icon Live chat